Clinical Trial

Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer

Study acronym: STA-RR-LC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 23, 2025 (before its estimated June 23, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this non experimental, transversal instrument study is to Construct and determine the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer in Mexican patients with a lung cancer diagnosis. The main question it aims to answer is: What is the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer of the patients with this diagnosis that are currently undergoing an assessment or follow up program of Respiratory Rehabilitation? The Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC) will be psychometrically valid and reliable for the evaluation of therapeutic adherence on patients with lung cancer that are undergoing an assessment or follow up of Respiratory Rehabilitation.Participants will be asked to fill out an Identification card and fill out the fifty-six items presented on the STA-RR-LC.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-21.
Trial Details
NCT Number NCT06477302
Lead Sponsor Instituto Nacional de Cancerologia de Mexico
Conditions Lung Cancer
Enrollment 281 participants
Start Date 2023-06-23
Primary Completion 2026-06-23 (estimated)
Study Completion 2027-06-23 (estimated)
Updated on ClinicalTrials.gov 2025-12-23